HSB 626 (LSB 5155DP (6) 83)

SENATE/HOUSE FILE _____

BY  (PROPOSED BOARD OF PHARMACY EXAMINERS BILL)

A BILL FOR

An Act making changes to the uniform controlled substances Act.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:

    Section 1.  Section 124.206, subsection 3, Code 2009, is amended by adding the following new paragraph:
   NEW PARAGRAPH.  ab.  Tapentadol.
    Sec. 2.  Section 124.210, subsection 3, Code 2009, is amended by adding the following new paragraph:
   NEW PARAGRAPH.  az.  Fospropofol.
    Sec. 3.  Section 124.212, subsection 5, Code Supplement 2009, is amended to read as follows:
   5.  Depressants.  Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of any of the following substance substances having a depressant effect on the central nervous system, including its salts of such substances:  pregabalin
   a.  Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-

propionamide].
   b.  Pregabalin [(S)-3-(aminomethyl)-5- methylhexanoic acid].
EXPLANATION
   This bill makes changes to the uniform controlled substances Act.
   The bill adds the substance “tapentadol” to the list of opiates classified as schedule II controlled substances.
   The bill adds the substance “fospropofol” to the list of depressants classified as schedule IV controlled substances.
   The bill adds the substance “lacosamide [(R)-2-acetoamido-

N-benzyl-3-methoxy-propionamide]” to the list of depressants classified as schedule V controlled substances.
   The substances added to the schedules by the bill are newly developed medications recently approved by the federal food and drug administration and are added to maintain uniformity between state and federal regulations.
   Iowa administrative code rules 657-10.1 through 657-10.40 govern the regulation of controlled substances.